The Effect of Accelerometer Guided App Feedback on Change in Activity in Patients With Low Back
Primary Purpose
Low Back Pain, Radiculopathy Lumbar, Sciatica
Status
Completed
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
The SENS motion® sensor
Sponsored by
About this trial
This is an interventional treatment trial for Low Back Pain
Eligibility Criteria
Inclusion Criteria:
- non-specific low back pain, spinal stenosis, radiculopathy
- moderate disability or worse (20-100 points on Oswestry Disability Index)
Exclusion Criteria:
- co-morbidity making the patients unable to move
- unsufficient Danish-skills
- patients who already monitored their activity by watch or phone on a daily basis
- allergy to band-aid
- pregnancy or breast-feeding
- patients referred for back-surgical evaluation
Sites / Locations
- COPEBACK, Rigshospitalet
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Initial activity tracker with feedback followed by control period
Initial control period followed by activity tracker with feedback
Arm Description
Initial activity tracker with feedback followed by control period
Initial control period followed by activity tracker with feedback
Outcomes
Primary Outcome Measures
Average daily activity
The Primary outcome was defined as the difference in average (mean) daily number of minutes in activity (defined as the sum of time spent with standing, walking, cycling and exercising) in 14 days intervention period compared to 14 days control period, registered by the sensor.
Secondary Outcome Measures
Full Information
NCT ID
NCT04695912
First Posted
December 8, 2020
Last Updated
January 3, 2021
Sponsor
Rigshospitalet, Denmark
1. Study Identification
Unique Protocol Identification Number
NCT04695912
Brief Title
The Effect of Accelerometer Guided App Feedback on Change in Activity in Patients With Low Back
Official Title
The Effect of Accelerometer Guided App Feedback on Change in Activity in Patients With Low Back Pain
Study Type
Interventional
2. Study Status
Record Verification Date
January 2021
Overall Recruitment Status
Completed
Study Start Date
April 26, 2019 (Actual)
Primary Completion Date
June 20, 2019 (Actual)
Study Completion Date
June 20, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
In a cross-over, open-label, randomized, controlled trial, the investigators aim to determine if the daily activity level in patients with LBP can be increased via feedback from an app, connected to a wearable sensor of physical activity.
Detailed Description
The aim of the study is to determine if a wearable device that measure physical activity and a smartphone application with nudges and feedback increase the physical activity level of patients with low back pain over a 14 days period.
Secondary to determine how many of the patients, that use the smartphone application, and if they perceived the feedback as inspiring.
And to explore, if a potential effect of the device and smartphone application depended on the baseline activity level, gender, diagnoses, age, education level and previous exercise experience.
Is there a difference in average (mean) daily number of active minutes (defined as walking, cycling, running or exercise) over the 14 days intervention period compared to the 14 days control period.
If there is an effect of the device and smartphone application, then determine how many of the patients, that use the smartphone application, and if they perceived the feedback as inspiring.
To explore, if a potential effect of the device and smartphone application depended on the baseline activity level, gender, diagnoses, age, education level and previous exercise experience.
Is the outcome measures; function measured by sensor, the subjective measurements as pain, stiffness and function, responsive to the intervention compared, to the global scale. 4. Is the patient´s self-evaluated change in activity in the intervention period compared to the baseline period and the control period corelated to the changes in activity measured by the sensor.
The investigators will make a Cross-over, randomized, open label, controlled trial.
Patients will be included from the outpatient clinic, The Department of Rheumatology, Rigshospitalet - Glostrup, Region Hovedstaden, Denmark Inclusions criteria
Aged 18 years or older
Non-specific low back pain, spinal stenosis or radiculopathy.
Not referred for surgical evaluation.
Patients who scored ≥ 20 point at the Oswestry Disability Index Exclusion criteria
Patients with comorbidity that prevent them for participating in the study.
Patients who are judge by the principal investigator to not speak Danish sufficiently to enable them to comprehend the study information and app feedback.
Patients who already monitor their activity by a watch, on a daily basis.
Patients with allergy for band aid
Patients who are pregnant or breastfeeding
The patients are randomized to start with intervention + standard-of-care or only standard-of-care. After completion of the first period the patients will cross-over to the other period.
The patients are randomized by closed envelope. Using a randomization list from randomization.com.
Intervention period
The patients wear the SENS motion patch for 14 days and received daily updates on activity, and suggestions for improvements. During the intervention period the patients receive standard-of-care.
Control period
The patients wear the SENS motion patch for 14 days, but do not receive any feedback from the sensor. During the control period the patients receive standard-of-care.
Standard-of-care
At the outpatient clinic patients are examined by a doctor, receive a diagnosis and may undergo MRI to identify other causes for back pain. They are not offered any training program at the hospital, but they are recommended to stay active and exercise. Some may have a consultation with a physiotherapist one to two times who repeat the advice. Patients are informed that despite pain, they cannot harm their spine by work, exercise or performing daily activities, and that medical staff do not discourage any activities.
Name of the investigational device
SENS motion®, SENS-Innovation ApS
Titangade 11, 2. - 2200 Kbh. N.
Sensor
The SENS motion® system consists of:
The sensor 'SENS Motion Patch'
A smart-phone application 'SENS motion´
SENS motion cloud storage database, a web-based visualization of data for the healthcare team
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain, Radiculopathy Lumbar, Sciatica
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
crossover, open-label, randomized, controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
98 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Initial activity tracker with feedback followed by control period
Arm Type
Other
Arm Description
Initial activity tracker with feedback followed by control period
Arm Title
Initial control period followed by activity tracker with feedback
Arm Type
Other
Arm Description
Initial control period followed by activity tracker with feedback
Intervention Type
Device
Intervention Name(s)
The SENS motion® sensor
Other Intervention Name(s)
iSpine app (InterMedCon)
Intervention Description
The sensor is a wearable physical tracker giving investigators feedback about daily activity
The SENS motion® system consists of:
The sensor 'SENS Motion Patch' A smart-phone application 'SENS motion´
SENS motion cloud storage database, a web-based visualization of data for the healthcare team
The iSpine app shows activity-information recorded by the sensor to the patient and gives nudges to activity.
Primary Outcome Measure Information:
Title
Average daily activity
Description
The Primary outcome was defined as the difference in average (mean) daily number of minutes in activity (defined as the sum of time spent with standing, walking, cycling and exercising) in 14 days intervention period compared to 14 days control period, registered by the sensor.
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
non-specific low back pain, spinal stenosis, radiculopathy
moderate disability or worse (20-100 points on Oswestry Disability Index)
Exclusion Criteria:
co-morbidity making the patients unable to move
unsufficient Danish-skills
patients who already monitored their activity by watch or phone on a daily basis
allergy to band-aid
pregnancy or breast-feeding
patients referred for back-surgical evaluation
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anna katrine Itenov, MD
Organizational Affiliation
COPEBACK, Rigshospitalet
Official's Role
Principal Investigator
Facility Information:
Facility Name
COPEBACK, Rigshospitalet
City
Copenhagen
Country
Denmark
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Effect of Accelerometer Guided App Feedback on Change in Activity in Patients With Low Back
We'll reach out to this number within 24 hrs